Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
第一作者:
Yan-Qiong,Zhang
第一单位:
Institute of Chinese Materials Medical, China Academy of Chinese Medical Sciences, Beijing, China.
作者:
医学主题词
动物(Animals);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);细胞凋亡(Apoptosis);癌, 肝细胞(Carcinoma, Hepatocellular);细胞增殖(Cell Proliferation);壳聚糖(Chitosan);二萜类(Diterpenes);环氧化合物(Epoxy Compounds);半乳糖(Galactose);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male);小鼠(Mice);小鼠, 裸(Mice, Nude);纳米粒子(Nanoparticles);菲类(Phenanthrenes);生殖(Reproduction);信号传导(Signal Transduction);组织分布(Tissue Distribution);肿瘤细胞, 培养的(Tumor Cells, Cultured);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1016/j.nano.2018.09.002
PMID
30244085
发布时间
2019-02-15
- 浏览27
Nanomedicine
86-97页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



